Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Shares of the Company’s common stock are traded on the New York Stock Exchange under the symbol “HR.” As of December 31, 2024, there were 2,009 stockholders of record.
Future dividends will be declared and paid at the discretion of the Board of Directors. The Company’s ability to pay dividends is dependent upon its ability to generate funds from operations and cash flows, and to make accretive new investments.
23
Equity Compensation Plan Information
The following table provides information as of December 31, 2024, about the Company’s common stock that may be issued as restricted stock and upon the exercise of options, warrants and rights under the Company’s existing compensation plans, including the Amended and Restated 2006 Incentive Plan.
PLAN CATEGORY NUMBER OF SECURITIES
TO BE ISSUED
upon exercise of outstanding options, warrants, and rights WEIGHTED AVERAGE EXERCISE PRICE
of outstanding options, warrants, and rights NUMBER OF SECURITIES REMAINING AVAILABLE
for future issuance under equity
compensation plans (excluding
securities reflected in the first column)
Equity compensation plans approved by security holders — — 6,140,496
Equity compensation plans not approved by security holders — — —
Total — — 6,140,496
Issuer Purchases of Equity Securities
During the year ended December 31, 2024, the Company withheld and canceled shares of Company common stock to satisfy employee tax withholding obligations payable upon the vesting of non-vested shares, as follows:
PERIOD TOTAL NUMBER OF SHARES PURCHASED AVERAGE PRICE PAID
per share TOTAL NUMBER OF SHARES purchased as part of publicly announced plans or programs MAXIMUM NUMBER OF SHARES
that may yet be purchased
under the plans or programs
February 1 - February 28 8,228 $ 16.31 — —
October 1 - October 31 93,965 17.16
December 1 - December 31 383,016 18.14 — —
Total 485,209 $ 17.92
Authorization to Repurchase Common Stock
During 2024, the Company repurchased shares of its common stock under repurchase authorizations as follows:
PERIOD TOTAL NUMBER OF SHARES PURCHASED (1) (2)
AVERAGE PRICE PAID per share TOTAL NUMBER OF SHARES purchased as part of publicly announced plans or programs (2)
MAXIMUM NUMBER (or Approximate DOLLAR VALUE) OF SHARES that may yet be purchased under the plans or programs (1)
Prior Authorizations
April 1 - April 30 2,966,764 $ 14.07 2,966,764
May 1 - May 31 7,536,692 15.94 7,536,692
June 1 - June 30 6,738,781 16.44 6,738,781
July 1 - July 31 1,296,985 16.82 1,296,985
August 1 - August 31 3,055,197 17.56 3,055,197
September 1 - September 30 4,140,669 17.97 4,140,669
October 1 - October 31 1,380,000 17.54 1,380,000
October 29, 2024 Authorized Shares $ 300,000,000
November 1 - November 30 1,554,958 17.22 1,554,958 273,224,084
December 1 - December 31 2,124,204 17.07 2,124,204 236,957,114
Total 30,794,250 $ 16.56 30,794,250 $ 236,957,114
1 On May 31, 2023, the Company's Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company's common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints, and other customary conditions. On April 30, 2024, the Company's Board of Directors authorized the repurchase of up to $500.0 million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization. On October 29, 2024, the Company's Board of Directors authorized the repurchase of up to $300.0 million of outstanding shares of the Company's common stock, superseding the previous stock repurchase authorization. The stock repurchase authorization expires on October 28, 2025, and the Company may suspend or terminate repurchases at any time without prior notice. The Company is not obligated under this authorization to repurchase any specific number of shares.
2 Repurchases of common stock in April 2024 were made under the May 31, 2023 $500.0 million stock repurchase authorization. May 2024 through October 2024 were repurchased under the April 30, 2024 $500.0 million stock repurchase authorization. November and December 2024 repurchases were repurchased under the October 29, 2024 $300.0 million stock repurchase authorization. As of December 31, 2024, the Company was authorized to repurchase an additional $237.0 million of the Company's common stock.
24
Stock Performance Graph
The following graph provides a comparison of the Company's cumulative total shareholder return with the Russell 3000 Index and cumulative total returns of FTSE NAREIT All Equity REITs Index for the period from December 31, 2019 through December 31, 2024. The comparison assumes $100 was invested on December 31, 2019, in the Company's common stock and in each of the indexes and assumes reinvestment of dividends, as applicable. The Company's data for periods prior to the closing of the Merger is the stock performance of Legacy HR.
Item 6. [Reserved]
25